These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20567570)

  • 1. A multidisciplinary approach to the management of hepatocellular carcinoma.
    Gish RG; Marrero JA; Benson AB
    Gastroenterol Hepatol (N Y); 2010 Mar; 6(3 Suppl 6):1-16. PubMed ID: 20567570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in the management of hepatocellular carcinoma.
    Wong R; Frenette C
    Gastroenterol Hepatol (N Y); 2011 Jan; 7(1):16-24. PubMed ID: 21346848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in multidisciplinary management of hepatocellular carcinoma.
    Gomaa AI; Waked I
    World J Hepatol; 2015 Apr; 7(4):673-87. PubMed ID: 25866604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for hepatocellular carcinoma.
    Sandhu DS; Tharayil VS; Lai JP; Roberts LR
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
    Poon RT; Fan ST; Tsang FH; Wong J
    Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional and systemic therapy for hepatocellular carcinoma.
    Gbolahan OB; Schacht MA; Beckley EW; LaRoche TP; O'Neil BH; Pyko M
    J Gastrointest Oncol; 2017 Apr; 8(2):215-228. PubMed ID: 28480062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review.
    Osaki Y; Nishikawa H
    Hepatol Res; 2015 Jan; 45(1):59-74. PubMed ID: 24965914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis.
    Salhab M; Canelo R
    J Cancer Res Ther; 2011; 7(4):463-75. PubMed ID: 22269411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.
    Gandhi M; Choo SP; Thng CH; Tan SB; Low AS; Cheow PC; Goh AS; Tay KH; Lo RH; Goh BK; Wong JS; Ng DC; Soo KC; Liew WM; Chow PK;
    BMC Cancer; 2016 Nov; 16(1):856. PubMed ID: 27821083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
    Yegin EG; Oymaci E; Karatay E; Coker A
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management.
    Elderkin J; Al Hallak N; Azmi AS; Aoun H; Critchfield J; Tobon M; Beal EW
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma.
    De Mattia E; Cecchin E; Guardascione M; Foltran L; Di Raimo T; Angelini F; D'Andrea M; Toffoli G
    World J Gastroenterol; 2019 Aug; 25(29):3870-3896. PubMed ID: 31413525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman OM; Elsayed Z
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
    Wang EA; Stein JP; Bellavia RJ; Broadwell SR
    Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
    Lencioni R; Chen XP; Dagher L; Venook AP
    Oncologist; 2010; 15 Suppl 4():42-52. PubMed ID: 21115580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated treatment approach to hepatocellular carcinoma.
    Llovet JM
    J Gastroenterol; 2005 Mar; 40(3):225-35. PubMed ID: 15830281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
    Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
    Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies.
    Makary MS; Khandpur U; Cloyd JM; Mumtaz K; Dowell JD
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management.
    Samant H; Amiri HS; Zibari GB
    J Gastrointest Oncol; 2021 Jul; 12(Suppl 2):S361-S373. PubMed ID: 34422400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.